Related Experiment Video
Updated: Jun 19, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Common genetic variants in sudden cardiac death
1Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232-0275, USA. al.george@vanderbilt.edu
Heart Rhythm
|November 3, 2009
Summary
Genetic factors significantly influence sudden cardiac death (SCD) risk. Common genetic variants and genome-wide association studies reveal new insights into population-level SCD risk and QT interval variations.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Population Genetics
Background:
- Genetic factors are crucial in sudden cardiac death (SCD) risk, supported by family, twin, and molecular studies.
- Rare inherited syndromes and common genetic variants contribute to SCD susceptibility.
- Understanding genetic contributions to common diseases requires basic genetic concepts.
Purpose of the Study:
- To review genetic risks for sudden cardiac death (SCD).
- To explain fundamental concepts of genetic contributions to common diseases.
- To highlight key genetic study categories impacting SCD research.
Main Methods:
- Review of family history, twin, and molecular studies.
- Analysis of candidate gene studies focusing on rare syndromes and autonomic function.
- Examination of genome-wide association studies (GWAS) for common variant discovery.
Main Results:
- Candidate gene studies identified genes linked to rare arrhythmias and autonomic control.
- GWAS revealed novel genomic regions associated with QT interval duration.
- These genetic variations contribute to population-attributable risk for SCD.
Conclusions:
- Genetic factors play a significant role in SCD etiology.
- Both rare and common genetic variants contribute to SCD risk.
- GWAS advances understanding of genetic determinants of QT interval and SCD risk.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...